Universitaetsklinikum Augsburg

Augsburg 86179

4 studies enrolling now · 10 studies all time

What they study most

B Cell Precursor Acute Lymphoblastic Leukemia, Breast Neoplasms, Crohn's Disease, Diabetes Mellitus, Type 1, Eosinophilic Esophagitis, Locally Advanced Basal Cell Carcinoma, Locally Advanced Cutaneous Squamous Cell Carcinoma, Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL), Prurigo Nodularis

Studies at this site

• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — Recruiting now
• L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) — Recruiting now
• L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma — Recruiting now
• L19IL2/TNF in Patients With Basal Cell Carcinoma — Recruiting now
• A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis — Stopped early
• A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease — Stopped early
• Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia — Running, not enrolling
• A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL — Running, not enrolling
• A Study of CDX-0159 in Patients With Eosinophilic Esophagitis — Completed
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling